Extended CCR5 Blockade for Graft-Versus-Host Disease Prophylaxis Improves Outcomes of Reduced Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial

Graft-versus-host disease (GVHD) remains the most common treatment-related complication after allogeneic hematopoietic cell transplantation (allo-HCT). Lymphocyte migration plays a critical role in the pathogenesis of GVHD. A previous phase I/II trial demonstrated that CCR5 blockade with maraviroc i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Reshef, Ran, Ganetsky, Alex, Acosta, Edward P., Blauser, Robin, Crisalli, Lisa, McGraw, Jessica, Frey, Noelle V., Hexner, Elizabeth O., Hoxie, James A., Loren, Alison W., Luger, Selina M., Mangan, James, Stadtmauer, Edward A., Mick, Rosemarie, Vonderheide, Robert H., Porter, David L.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6445759/
https://ncbi.nlm.nih.gov/pubmed/30315941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.09.034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars